Multiple studies have attempted to update the definition of PE by incorporation of crucial biomarkers released from either placenta or blood vessels, such as VEGF, PlGF, sFlt-1, or sEng in the diagnosis of preeclampsia and even predicting disease development and its outcome [35–37]. Here, VEGFA is linked to preeclampsia.